J. Goldman & Co LP - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$704,000
-33.3%
41,500
-21.0%
0.04%
-26.9%
Q1 2017$1,055,000
-5.2%
52,500
-26.5%
0.05%
-29.7%
Q4 2016$1,113,00071,4000.07%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Prentice Capital Management, LP 390,381$1,292,0000.49%
ETF MANAGERS GROUP, LLC 891,025$2,949,0000.09%
AdvisorShares Investments LLC 353,009$1,168,0000.06%
ALGERT GLOBAL LLC 51,028$169,0000.05%
Bernardo Wealth Planning LLC 27,219$90,0000.04%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 31,552$104,0000.03%
ZEKE CAPITAL ADVISORS, LLC 49,700$165,0000.02%
Walleye Capital LLC 51,554$171,0000.02%
Dynamic Technology Lab Private Ltd 19,021$63,0000.01%
J.W. COLE ADVISORS, INC. 37,064$123,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders